Peripheral inflammatory and fibrinolytic markers in adolescents with growth hormone deficiency: Relation to postprandial dyslipidemia

Journal of Pediatrics

Volumn 145, Issue 5, 2004, Pages 657-661

  Lanes, Roberto ^a,b   Paoli, Mariela ^a   Carrillo, Eduardo ^a   Villaroel, Omar ^a   Palacios, Anselmo ^a  

^a UNIVERSIDAD DE LOS ANDES   (Venezuela)

^b Miami FL 33102 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; GROWTH HORMONE; INTERLEUKIN 6; LIPOPROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EVALUATION; FEMALE; FIBRINOLYSIS; GROWTH HORMONE DEFICIENCY; HUMAN; LIPID DIET; MALE; POSTPRANDIAL STATE; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHILD; FASTING; FEMALE; FIBRINOGEN; HUMAN GROWTH HORMONE; HUMANS; INTERLEUKIN-6; MALE; POSTPRANDIAL PERIOD; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 7444223520     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2004.07.037     Document Type: Article

References (21)

1. R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 340 1999 115 126
2. C.R. Weiss, A.E. Arai, M.N. Bui, K.O. Agyeman, M.A. Waclawiw, and R.S. Balaban Arterial wall MRI characteristics are associated with elevated markers of inflammation in humans J Magnetic Resonance Imag 14 2001 698 704
3. P.M. Ridker, N. Rifai, M.J. Stampfer, and C.H. Hennekens Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men Circulation 101 2000 1767 1772
4. P.M. Ridker, C.H. Hennekens, J.E. Buring, and N. Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843
5. J.S. Yudkin, M. Kumari, S.E. Humphries, and V. Mohamed-Ali Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148 2000 209 214
6. F. Samad, G. Bergtrom, and D.L. Amrani Regulation of plasminogen activation by interleukin-6 in human lung fibroblasts Biochimica Biophysica Acta 1221 1994 307 314
7. K.A.S. Al-Shoumer, K.H. Cox, C.L. Hughes, W. Richmond, and D.G. Johnston Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy J Clin Endocrinol Metab 82 1997 2653 2659
8. T.B. Twickler, H.W. Wilmink, N.J. Schreuder, M. Casto Cabezas, P.S. van Dam, and D. Koppeschaar Growth hormone (GH) treatment decreases postprandial remnant-like particle cholesterol concentration and improves endothelial function in adult-onset GH deficiency J Clin Endocrinol Metab 85 2000 4683 4689
9. T.B. Twickler, G.M. Dallinga-Thie, F.L.J. Visseren, W.R. De Vries, D.W. Erkelens, and H.P.F. Kopperschaar Induction of postprandial inflammatory response in adult onset growth hormone deficiency is related to plasma remnant-like particle-cholesterol concentration J Clin Endocrinol Metab 88 2003 1228 1233
10. M. Leonsson, J. Hulthe, G. Johannsson, O. Wiklund, J. Wikstrandt, and B.A. Bengtsson Increased interleukin-6 levels in pituitary-deficient patients are independently related to their carotid intima-media thickness Clin Endocrinol 59 2003 242 250
11. O. Serri, P. St-Jaques, M. Sartippour, and G. Renier Alterations of monocyte function in patients with growth hormone (GH) deficiency: effect of substitutive GH therapy J Clin Endocrinol Metab 84 1999 58 63
12. R. Lanes, P. Gunczler, E. Lopez, S. Esaa, O. Villaroel, and R. Revel-Chion Cardiac mass and function, carotid artery intima-media thickness and lipoprotein levels in growth hormone deficient adolescents J Clin Endocrinol Metab 86 2001 1061 1065
13. R. Lanes, M. Paoli, E. Carrillo, O. Villaroel, and A. Palacios The cardiovascular risk of growth hormone deficient adolescents: differences in growth hormone treated and untreated subjects Horm Res 60 2003 291 295
14. R. Lanes, B. Recker, P. Fort, and F. Lifshitz Low dose oral clonidine: a simple and reliable growth hormone screening test for children Am J Dis Child 139 1985 87 89
15. M. Donnadieu, D. Evain-Brion, M.Cl. Tonon, H. Vaudry, and J.C. Job Variations of plasma growth hormone (GH)-releasing factor levels during GH stimulation tests in children J Clin Endocrinol Metab 60 1985 1132 1134
16. G. Sesmilo, B.M. Biller, J. Llevadot, D. Hayden, G. Hanson, and N. Rifai Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized controlled clinical trial Ann Intern Med 133 2000 111 122
17. J. Koranyi, J. Svensson, G. Gotherstrom, K.S. Sunnerhagen, B.-A Bengtsson, and G. Johannsson Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study J Clin Endocrinol Metab 86 2001 4693 4699
18. F. Karpe Postprandial lipoprotein metabolism and atherosclerosis J Intern Med 246 1999 341 355
19. S. Boquist, G. Ruotolo, R. Tang, J. Bjorkegren, M.G. Bond, and U. De Faire Alimentary lipemia, postprandial triglyceride-rich lipoproteins and common carotid intima-media thickness in healthy middle aged men Circulation 100 1999 723 728
20. T. Kearny, C.N. De Gallegos, A. Chrisoulidou, R. Gray, P. Bannister, and S. Venkatesan Hypopituitarism is associated with triglyceride enrichment of very low-density lipoproteins J Clin Endocrinol Metab 86 2001 3900 3906
21. G. Aimaretti, G. Cornelli, S. Bellone, C. Baffoni, F.Y. Camanni, and E. Ghigo Growth hormone deficiency in the transition adolescent: should treatment be continued in adult life J Pediatr Endocrinol Metab 14 2001 1233 1242